drugset / Trial / NCT00751400

Naproxen Sodium Extended-Release Actual Use Study

NCT00751400

Phase 3 Completed 497 enrolled Bayer Pegus Research, Inc. · collab
Non-randomizedSingle-groupOpen-label

Summary

The purpose of this Study is to assess how subjects will use the investigational product in an uncontrolled, naturalistic environment.

Timeline

Start
2008-07
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule

Indications

No indication recorded.